Total Payments
$1,967
2022 Payments
$872.55
Companies
15
Transactions
92
Medicare Patients
283
Medicare Billing
$46,131
Payment Breakdown by Category
Food & Beverage$1,967 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,967 | 92 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $530.50 | 32 | $0 (2022) |
| Validus Pharmaceuticals LLC | $468.74 | 2 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $279.85 | 15 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $187.44 | 12 | $0 (2022) |
| Lundbeck LLC | $117.65 | 8 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $106.81 | 6 | $0 (2022) |
| Indivior Inc. | $47.91 | 3 | $0 (2022) |
| Alkermes, Inc. | $44.33 | 3 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $41.70 | 2 | $0 (2022) |
| Noven Therapeutics, LLC | $40.54 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $872.55 | 53 | ABBVIE INC. ($367.23) |
| 2021 | $1,094 | 39 | Validus Pharmaceuticals LLC ($448.89) |
All Payment Transactions
92 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/23/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: Central Nervous System | ||||||
| 08/05/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.69 | General |
| Category: NEUROSCIENCE | ||||||
| 07/28/2022 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.63 | General |
| Category: PSYCHIATRY | ||||||
| 07/27/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Neuroscience | ||||||
| 07/20/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $8.89 | General |
| 07/19/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: PSYCHIATRY | ||||||
| 07/07/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: Central Nervous System | ||||||
| 07/06/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: NEUROSCIENCE | ||||||
| 06/29/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Central Nervous System | ||||||
| 06/23/2022 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: BH | ||||||
| 06/22/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: PSYCHIATRY | ||||||
| 06/21/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: NEUROSCIENCE | ||||||
| 06/16/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: NEUROSCIENCE | ||||||
| 06/15/2022 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.43 | General |
| Category: PSYCHIATRY | ||||||
| 06/09/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Central Nervous System | ||||||
| 06/08/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.01 | General |
| Category: NEUROSCIENCE | ||||||
| 06/01/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: NEUROSCIENCE | ||||||
| 05/25/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: PSYCHIATRY | ||||||
| 05/24/2022 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: BH | ||||||
| 05/18/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: NEUROSCIENCE | ||||||
| 05/12/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: Central Nervous System | ||||||
| 05/11/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2022 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.50 | General |
| Category: PSYCHIATRY | ||||||
| 05/10/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.66 | General |
| Category: NEUROSCIENCE | ||||||
| 05/05/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 72 | 315 | $70,605 | $20,783 |
| 2022 | 5 | 116 | 266 | $53,860 | $15,865 |
| 2021 | 4 | 95 | 164 | $24,701 | $9,483 |
Total Patients
283
Total Services
745
Medicare Billing
$46,131
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 184 | $45,080 | $14,054 | 31.2% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 25 | 118 | $20,650 | $5,086 | 24.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 13 | 13 | $4,875 | $1,643 | 33.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 109 | $24,905 | $7,222 | 29.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 18 | 55 | $9,625 | $2,485 | 25.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 55 | $8,500 | $2,476 | 29.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 22 | 30 | $4,230 | $2,040 | 48.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $6,600 | $1,643 | 24.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 31 | 56 | $12,320 | $3,701 | 30.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 24 | 60 | $5,460 | $2,876 | 52.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 27 | 31 | $4,371 | $2,134 | 48.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 17 | $2,550 | $771.12 | 30.2% |
About Kimberly Cromer
Kimberly Cromer is a Psychiatric/Mental Health healthcare provider based in North Ridgeville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2020. The National Provider Identifier (NPI) number assigned to this provider is 1063030765.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kimberly Cromer has received a total of $1,967 in payments from pharmaceutical and medical device companies, with $872.55 received in 2022. These payments were reported across 92 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,967).
As a Medicare-enrolled provider, Cromer has provided services to 283 Medicare beneficiaries, totaling 745 services with total Medicare billing of $46,131. Data is available for 3 years (2021–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatric/Mental Health
- Location North Ridgeville, OH
- Active Since 07/09/2020
- Last Updated 07/09/2020
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1063030765
Products in Payments
- VRAYLAR (Drug) $521.61
- Equetro (Drug) $468.74
- REXULTI (Drug) $294.69
- AUSTEDO (Drug) $187.44
- INVEGA SUSTENNA (Drug) $106.81
- ABILIFY MAINTENA (Drug) $102.81
- PERSERIS (Drug) $47.91
- ARISTADA (Drug) $44.33
- TRINTELLIX (Drug) $41.70
- SECUADO (Drug) $40.54
- LATUDA (Drug) $31.55
- GRALISE (Drug) $19.60
- HETLIOZ (Drug) $19.54
- CAPLYTA (Drug) $16.00
- Kloxxado (Drug) $14.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.